Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Medicine and Health, Rhode Island
|
December 30, 2011
Monoclonal antibodies: an introduction
Syed A Rizvi
Neurology
|
December 30, 2004
Other therapy options and future strategies for treating patients with multiple sclerosis
Syed A Rizvi, Khurram Bashir
Medicine and Health, Rhode Island
|
December 30, 2011
The role of monoclonal antibodies in neurological disorders
Valerie Gendron, Syed A Rizvi
Cureus
|
April 15, 2026
Shifting Focus: An Advocacy-Focused Analysis of Omega Beta Iota's Membership and Political Engagement Strategies
Mishalle F Rashid, Syed A Rizvi
Neurology
|
December 30, 2004
Current approved options for treating patients with multiple sclerosis
Syed A Rizvi, Mark A Agius
Neurology
|
April 24, 2002
Symptomatic therapy for underrecognized manifestations of multiple sclerosis
Lauren B Krupp, Syed A Rizvi
International Journal of Nanomedicine
|
August 28, 2007
Glatiramer in the treatment of multiple sclerosis
Syed A Rizvi, Edward Kim, Jennifer Moodie
Frontiers in Allergy
|
July 25, 2024
Editorial: Biological therapy for allergic diseases: peculiarities, prospects, and challenges
Ervin Ç Mingomataj, Tayseer Ibrahim, Syed A Rizvi
Neurology
|
December 30, 2004
Mitoxantrone for multiple sclerosis in clinical practice
Syed A Rizvi, Howard Zwibel, Edward J Fox
Multiple Sclerosis and Related Disorders
|
November 12, 2019
Vascular malformations masquerading as demyelinating disease
Gabriel Lupu, Jonathan F Cahill, Syed A Rizvi
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Medicine and Health, Rhode Island
|
December 30, 2011
Monoclonal antibodies: an introduction
Syed A Rizvi
Neurology
|
December 30, 2004
Other therapy options and future strategies for treating patients with multiple sclerosis
Syed A Rizvi, Khurram Bashir
Medicine and Health, Rhode Island
|
December 30, 2011
The role of monoclonal antibodies in neurological disorders
Valerie Gendron, Syed A Rizvi
Cureus
|
April 15, 2026
Shifting Focus: An Advocacy-Focused Analysis of Omega Beta Iota's Membership and Political Engagement Strategies
Mishalle F Rashid, Syed A Rizvi
Neurology
|
December 30, 2004
Current approved options for treating patients with multiple sclerosis
Syed A Rizvi, Mark A Agius
Neurology
|
April 24, 2002
Symptomatic therapy for underrecognized manifestations of multiple sclerosis
Lauren B Krupp, Syed A Rizvi
International Journal of Nanomedicine
|
August 28, 2007
Glatiramer in the treatment of multiple sclerosis
Syed A Rizvi, Edward Kim, Jennifer Moodie
Frontiers in Allergy
|
July 25, 2024
Editorial: Biological therapy for allergic diseases: peculiarities, prospects, and challenges
Ervin Ç Mingomataj, Tayseer Ibrahim, Syed A Rizvi
Neurology
|
December 30, 2004
Mitoxantrone for multiple sclerosis in clinical practice
Syed A Rizvi, Howard Zwibel, Edward J Fox
Multiple Sclerosis and Related Disorders
|
November 12, 2019
Vascular malformations masquerading as demyelinating disease
Gabriel Lupu, Jonathan F Cahill, Syed A Rizvi
Page
of 3